Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Total revenue	$ 114,701	$ 0	$ 0
Operating expenses:
Research and development	138,487	135,304	170,919
In process research and development	0	10,000	65
General and administrative	36,133	38,455	47,609
Total operating expenses	174,620	183,759	218,593
Loss from operations	(59,919)	(183,759)	(218,593)
Other income (expense)
Interest income	1,779	1,997	1,583
Interest expense	(11,517)	(13,511)	(13,880)
Other income, net	14,022	15,456	1,512
Total other income (expense), net	4,284	3,942	(10,785)
Loss before provision for income taxes	(55,635)	(179,817)	(229,378)
Provision for income taxes	893	0	0
Net loss	(56,528)	(179,817)	(229,378)
Other comprehensive income (loss):
Foreign currency translation	1,450	33	(544)
Unrealized income (loss) on marketable securities	89	191	(75)
Other comprehensive income (loss)	1,539	224	(619)
Comprehensive loss	$ (54,989)	$ (179,593)	$ (229,997)
Net loss per share, basic (in dollars per share)	$ (0.25)	$ (1.18)	$ (2.71)
Net loss per share, diluted (in dollars per share)	$ (0.25)	$ (1.18)	$ (2.71)
Weighted average common shares outstanding, basic (in shares)	226,228,016	152,621,669	84,574,869
Weighted average common shares outstanding, diluted (in shares)	226,228,016	152,621,669	84,574,869
Revenue from sale of licenses
Revenue:
Total revenue	$ 90,682	$ 0	$ 0
Revenue from contracts with collaborators
Revenue:
Total revenue	$ 24,019	$ 0	$ 0